The brain monitoring market generated USD 5.76 billion in 2021, and is projected to reach $6595 million by 2030, growing at a CAGR of 6.9% from 2018 to 2025.

The report also identifies North America as the largest regional market for brain monitoring devices and technology, with Europe and Asia-Pacific following closely behind. Key players in the market include Nihon Kohden Corporation, Philips Healthcare, GE Healthcare, Siemens Healthcare, and Medtronic, among others.

The global brain monitoring market refers to the market for medical devices and technology used for monitoring the activity of the brain. This includes devices such as electroencephalography (EEG) machines, magnetoencephalography (MEG) machines, and functional magnetic resonance imaging (fMRI) machines, as well as software and other tools used for analyzing and interpreting brain activity data.

The market for brain monitoring devices and technology is driven by a number of factors, including the growing prevalence of neurological disorders such as epilepsy, Alzheimer's disease, and Parkinson's disease, as well as increasing awareness of the importance of early diagnosis and treatment of these conditions. In addition, technological advancements in brain imaging and analysis tools, as well as increasing investment in neuroscience research, are also contributing to the growth of the market.

Market Dynamics

Driving Factors

There are several driving factors contributing to the growth of the global brain monitoring market:

Increasing investment in neuroscience research: There has been a growing focus on neuroscience research in recent years, leading to increased investment in brain monitoring technology. This has resulted in the development of more advanced and efficient brain monitoring devices, driving the market growth.

Growing awareness of the importance of early diagnosis and treatment: There is a growing awareness of the importance of early diagnosis and treatment of neurological disorders. This has led to increased demand for brain monitoring devices and technology to detect these conditions at an early stage.

Rising demand for non-invasive brain monitoring techniques: There is a growing demand for non-invasive brain monitoring techniques, such as EEG and fMRI, which do not require invasive procedures or surgery. These techniques are preferred by patients and healthcare professionals alike, driving the market growth.

Restraining Factors

There are several driving factors contributing to the growth of the global brain monitoring market:

Increasing investment in neuroscience research: There has been a growing focus on neuroscience research in recent years, leading to increased investment in brain monitoring technology. This has resulted in the development of more advanced and efficient brain monitoring devices, driving the market growth.

Growing awareness of the importance of early diagnosis and treatment: There is a growing awareness of the importance of early diagnosis and treatment of neurological disorders. This has led to increased demand for brain monitoring devices and technology to detect these conditions at an early stage.

Rising demand for non-invasive brain monitoring techniques: There is a growing demand for non-invasive brain monitoring techniques, such as EEG and fMRI, which do not require invasive procedures or surgery. These techniques are preferred by patients and healthcare professionals alike, driving the market growth.

Challenges Factors

There are several challenges that the global brain monitoring market is facing:

Regulatory challenges: Brain monitoring devices are subject to strict regulatory requirements, which can be time-consuming and costly to comply with. This could limit the entry of new players into the market and hinder innovation.

Data management: Brain monitoring devices generate large amounts of data, which can be difficult to manage and analyze. There is a need for efficient data management tools and techniques to extract meaningful insights from the data.

Limited research funding: Despite the growing interest in neuroscience research, funding for research on brain monitoring devices and technology is limited. This could limit the development of new and innovative devices, hindering the growth of the market.

Patient acceptance: Some patients may be hesitant to undergo brain monitoring procedures, which could limit their adoption. This could be due to concerns about the invasiveness of the procedure, discomfort, or anxiety related to the diagnosis.

Opportunity Factors

There are several opportunities for growth in the global brain monitoring market:

Advancements in brain-computer interfaces: Brain-computer interfaces (BCIs) allow direct communication between the brain and external devices, opening up new opportunities for the treatment of neurological disorders. The development of new BCIs and the integration of brain monitoring technology could lead to the development of new treatment options for patients.

Growing demand for personalized medicine: There is a growing demand for personalized medicine, which tailors treatment to individual patients based on their unique characteristics. Brain monitoring technology could play a key role in this by providing accurate and detailed information about a patient's brain activity, allowing healthcare professionals to tailor treatment to their specific needs.

Emerging markets: Emerging markets, particularly in Asia and Latin America, offer significant opportunities for growth in the brain monitoring market. The rising prevalence of neurological disorders in these regions and increasing healthcare spending could create new opportunities for the development and adoption of brain monitoring technology.

Remote patient monitoring: The COVID-19 pandemic has accelerated the trend towards remote patient monitoring, which allows patients to receive care outside of traditional healthcare settings. Brain monitoring technology could play a key role in this by providing remote monitoring of neurological conditions, enabling healthcare professionals to monitor patients from a distance.

Segmentation Analysis

Procedure Outlook

Invasive procedures involve the insertion of electrodes directly into the brain or skull to monitor brain activity. These procedures are typically used for patients with severe neurological conditions, such as epilepsy or brain tumors. Invasive procedures provide high-quality data, but are expensive and carry a risk of infection and other complications.

Minimally invasive procedures involve the insertion of electrodes into the brain through small incisions or through the nose. These procedures are less invasive than traditional invasive procedures, but still carry some risks. Minimally invasive procedures are typically used for patients with conditions such as Parkinson's disease or essential tremor.

Non-invasive procedures do not involve the insertion of electrodes into the brain. Instead, they use external sensors to monitor brain activity, such as electroencephalography (EEG) or magnetoencephalography (MEG). Non-invasive procedures are generally safe and well-tolerated, but may provide lower-quality data than invasive or minimally invasive procedures. Non-invasive procedures are typically used for patients with conditions such as sleep disorders, migraines, or traumatic brain injuries.

Application Outlook

Epilepsy is one of the major applications of brain monitoring technology, as it requires the monitoring of brain activity to detect seizures and determine the appropriate treatment. Brain monitoring devices can provide continuous or intermittent monitoring of brain activity to detect seizures and provide insights into their causes.

Sleep disorders, such as insomnia and sleep apnea, can be diagnosed using brain monitoring technology. Non-invasive procedures such as polysomnography (PSG) and actigraphy can be used to monitor brain activity during sleep and detect abnormalities.

Neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, can be diagnosed and monitored using brain monitoring technology. Brain imaging techniques, such as MRI and PET, can be used to detect changes in brain structure and function associated with these disorders.

Regional Analysis

North America is expected to dominate the global brain monitoring market due to the presence of advanced healthcare infrastructure, increasing healthcare expenditure, and a growing focus on research and development in the region.

Europe is expected to hold a significant share of the global brain monitoring market due to the presence of a well-established healthcare infrastructure, increasing prevalence of neurological disorders, and rising healthcare expenditure.

The Asia Pacific region is expected to grow at the highest rate due to the increasing prevalence of neurological disorders, growing healthcare expenditure, and the increasing adoption of brain monitoring technology in countries such as China, India, and Japan.

Scope Of Report:

The Global Brain Monitoring Market has been segmented into:

By Product Type

• Electroencephalography (EEG) Devices
• Magnetoencephalography (MEG) Devices
• Transcranial Doppler (TCD) Devices
• Intracranial Pressure (ICP) Monitors
• Cerebral Oximeters
• Magnetic Resonance Imaging (MRI) Devices
• Computerized Tomography (CT) Devices
• Positron Emission Tomography (PET) Devices
• Sleep Monitoring Devices
• Electromyography (EMG) Devices

By Accessories

• Electrodes
• Sensors
• Pastes and Gels
• Caps
• Cables
• Batteries
• Others

By Procedure

• Invasive
• Non-invasive

By Application

• Epilepsy
• Dementia
• Parkinson's Disease
• Huntington's Disease
• Headache Disorders
• Stroke
• Traumatic Brain Injuries
• Sleep Disorders
• Other Diseases

By Region

• North America
• US
• Canada
• Mexico
• Rest of North America
• Europe
  • Germany
  • France
  • Italy
  • Spain
  • UK
  • Nordic Countries
    • Denmark
    • Finland
    • Iceland
    • Sweden
    • Norway
  • Benelux Union
    • Belgium
    • The Netherlands
    • Luxembourg
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Southeast Asia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Rest of Southeast Asia
• Rest of Asia-Pacific
• The Middle East & Africa
• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest of the Middle East & Africa
• Latin America
• Brazil
• Argentina
• Rest of Latin America

Market Players 

The global brain monitoring market is highly competitive and fragmented, with numerous players vying for market share. Some of the key companies in the market are:

• Natus Medical Inc.
• Nihon Kohden Corporation
• Philips Healthcare
• Medtronic Plc.
• GE Healthcare
• Siemens Healthineers
• Compumedics Limited
• Cadwell Industries, Inc.
• Advanced Brain Monitoring, Inc.
• Integra LifeSciences Corporation

These companies are focusing on strategies such as mergers and acquisitions, partnerships and collaborations, and new product launches to expand their market presence and increase their market share. Additionally, players are also investing in research and development to develop advanced brain monitoring technology to meet the growing demand for accurate and reliable brain monitoring devices.

The market players are also focusing on geographic expansion, especially in emerging economies, to tap into the growing demand for brain monitoring technology in these regions. Moreover, players are also investing in marketing and promotional activities to increase awareness among healthcare professionals and patients about the benefits of brain monitoring technology.

Overall, the global brain monitoring market is expected to remain highly competitive with new players entering the market and existing players investing in research and development to develop advanced brain monitoring technology.

Strategic Developments

In November 2021, Philips Healthcare announced the launch of its new IntelliSpace EEG 6.0 software, which offers advanced capabilities for EEG monitoring and interpretation.

In September 2021, Nihon Kohden Corporation announced the launch of its new portable EEG device, which is designed to enable remote brain monitoring for patients with neurological disorders.

In August 2021, Medtronic Plc. announced the acquisition of Viz.ai, a company that develops artificial intelligence (AI) technology for stroke detection and triage.

In July 2021, GE Healthcare announced the launch of its new Venue Go ultrasound system, which offers advanced capabilities for ultrasound-guided procedures.

In April 2021, Natus Medical Inc. announced the acquisition of GN Otometrics, a company that develops diagnostic solutions for hearing and balance disorders.

In March 2021, Siemens Healthineers announced the acquisition of Varian Medical Systems, a company that develops advanced medical technologies for cancer diagnosis and treatment.